Literature DB >> 29625798

Avascular Necrosis of the Metacarpal Head: A Review of 4 Cases.

Salah Aldekhayel1, Erfan Ghanad1, Chaitanya S Mudgal2.   

Abstract

PURPOSE: To report on 4 cases of avascular necrosis of the metacarpal head.
METHODS: We retrospectively reviewed 4 patients who received a diagnosis of avascular necrosis of the metacarpal head and were treated from 2000 to 2016.
RESULTS: All patients were males with involvement of the dominant hand. Three patients had a history of trauma and/or fractures in another finger and one had a history of fracture in the same finger. The diagnosis was confirmed on regular x-rays and magnetic resonance imaging. Nonsurgical management was offered to all patients (rest, placement of an orthosis, and nonsteroidal anti-inflammatory drugs) for 3 to 6 months. Two patients responded well to nonsurgical management and improved in their symptoms. One patient refused surgical intervention and continued to have persistent pain. The other patient was treated with curettage and bone graft and had total resolution of pain symptoms with full active range of motion.
CONCLUSIONS: A high index of suspicion is required to diagnose and treat avascular necrosis of the metacarpal head correctly. Treatment options are numerous and require further studies to investigate their effectiveness in the treatment of this rare disease. TYPE OF STUDY/LEVEL OF EVIDENCE: Therapeutic V.
Copyright © 2018 American Society for Surgery of the Hand. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Avascular necrosis; Dieterich disease; Mauclaire disease; osteonecrosis

Mesh:

Substances:

Year:  2018        PMID: 29625798     DOI: 10.1016/j.jhsa.2018.03.002

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  1 in total

1.  Metacarpophalangeal Joint Denervation in the Treatment of Dieterich Disease: A Case Report.

Authors:  James Ross Bailey; Paul W Gorman; Andrew J Mitchelson
Journal:  Hand (N Y)       Date:  2020-10-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.